Profile data is unavailable for this security.
About the company
Biogened SA is a Poland-based company active in the healthcare sector. The Company is engaged in production and distribution of generic pharmaceuticals in psychiatry, neurology and oncology, as well as development, production and distribution of dermocosmetics and diet supplements. The Company’s product portfolio includes: Polmantis and SST Salvia Stimulating Tablets (pharmaceuticals), Dermedic, Ellexir, Herba Botanic and Novoscabin (dermocosmetics), and Fibers, Prolady, Futimal and Dermedic Caps (diet supplemenst). As of March 31, 2012, Life Science Technologies NV held an 80.92% stake in the capital.
- Revenue in PLN (TTM)115.12m
- Net income in PLN5.73m
- Incorporated2007
- Employees223.00
- LocationBiogened SAul. Pojezierska 99LODZ 91-342PolandPOL
- Phone+48 426513152
- Fax+48 426511243
- Websitehttps://www.biogened.pl/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLIS Technologies Ltd | 30.68m | 2.20m | 49.27m | 39.00 | 23.29 | 1.70 | 14.99 | 1.61 | 0.0007 | 0.0007 | 0.0102 | 0.01 | 1.02 | -- | 11.80 | 367,282.10 | 7.31 | -3.44 | 8.17 | -3.97 | -- | -- | 7.18 | -3.72 | 6.32 | 30.35 | 0.0396 | -- | 9.70 | 3.51 | 29.72 | -12.16 | 23.66 | -- |
| Krebs Biochemicals And Industries Ltd | 9.02m | -8.96m | 49.53m | 202.00 | -- | -- | -- | 5.49 | -10.60 | -10.60 | 10.68 | -74.60 | -- | -- | -- | 1,139,753.00 | -- | -16.90 | -- | -26.56 | 96.27 | 20.39 | -99.30 | -55.63 | 0.0359 | -2.42 | 3.65 | -- | -14.10 | 5.33 | -36.55 | -- | -17.65 | -- |
| BIOGENED SA | 115.12m | 5.73m | 51.58m | 223.00 | 8.99 | 1.18 | 5.64 | 0.4481 | 2.33 | 2.33 | 46.87 | 17.84 | 1.33 | 1.74 | 5.43 | -- | 5.63 | 4.16 | 7.43 | 6.02 | 65.25 | 68.27 | 4.24 | 3.96 | 1.40 | 3.83 | 0.3443 | -- | 16.09 | 18.93 | 14.22 | 35.56 | 8.39 | -- |
| Phapros Tbk PT | 180.66m | -44.23m | 52.12m | 1.26k | -- | 0.6336 | -- | 0.2885 | -249.48 | -249.48 | 1,019.16 | 463.99 | 0.547 | 2.36 | 1.88 | 649,537,700.00 | -13.71 | -2.15 | -21.02 | -4.11 | 41.26 | 48.61 | -25.06 | -3.95 | 1.02 | -2.19 | 0.6425 | -- | -25.80 | -7.60 | -3,721.67 | -- | -13.99 | -- |
| Millennium Pharmacon Internationl Tbk PT | 843.07m | 3.55m | 52.70m | 1.18k | 14.86 | 0.8314 | 6.21 | 0.0625 | 13.19 | 13.19 | 3,135.74 | 235.76 | 2.17 | 6.55 | 4.68 | 3,382,665,000.00 | 0.9118 | 1.26 | 4.42 | 5.88 | 8.49 | 8.44 | 0.4208 | 0.5389 | 0.7363 | 1.36 | 0.7385 | 11.73 | 16.45 | 7.51 | -48.84 | 16.53 | 5.53 | 14.87 |
| Laboratorio Farmaceutico Erfo SpA | 32.37m | 1.63m | 53.83m | 47.00 | 31.28 | 1.53 | 9.52 | 1.66 | 0.0454 | 0.0454 | 0.8964 | 0.9299 | 0.6734 | 3.86 | 7.09 | 187,405.60 | 4.69 | 9.36 | 5.99 | 11.50 | 38.27 | 47.80 | 6.97 | 15.92 | 1.21 | 19.41 | 0.1559 | -- | 1.59 | 6.03 | -33.74 | -22.47 | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -43.16m | 53.95m | 2.00 | -- | 1.80 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| Sotac Pharmaceuticals Ltd | 31.90m | 3.41m | 54.12m | 67.00 | 15.88 | 2.48 | 9.12 | 1.70 | 7.87 | 7.87 | 73.61 | 50.39 | 0.6818 | 2.86 | 2.67 | 12,149,600.00 | 8.46 | 5.81 | 16.28 | 12.47 | 37.26 | 25.59 | 12.40 | 4.69 | 0.9737 | 2.30 | 0.3854 | -- | -6.59 | 27.66 | 124.25 | 146.89 | 11.66 | -- |
| CASI Pharmaceuticals Inc | 95.26m | -175.22m | 54.57m | 233.00 | -- | -- | -- | 0.5728 | -2.98 | -2.98 | 1.62 | -1.85 | 0.6096 | 1.60 | 4.22 | 115,218.90 | -107.02 | -36.27 | -277.91 | -51.90 | 53.68 | 57.36 | -175.56 | -124.01 | 0.236 | -13.27 | -- | -- | -15.77 | 47.19 | -45.62 | -- | -55.67 | -- |
Data as of Feb 12 2026. Currency figures normalised to Biogened SA's reporting currency: Polish New Zloty PLN
